Researchers identified how a brain circuit involving dopamine and GLP-1 receptor impact palatability and hedonic eating.

The drug has been approved to help treat type-2 diabetes, but a new study shows an increase in use in people with type-1 diabetes, and it may not be safe.

There’s no question about the popularity of GLP-1 weight loss drugs like Ozempic and Wegovy, but some doctors are worried the ...

OB-GYNs explain how they're using semaglutide and tirzepatide to treat symptoms of PCOS. The meds help treat weight gain, ...

Here’s some of our top analysis to help you make sense of it all. Accountable care organizations and healthcare providers are ...

Drugs like Ozempic, Wegovy, and Saxenda have become hugely popular. But could they cause psychological side effects in their ...

Recognizing how persistent depressive disorder manifests and plays out in the lives of individuals suffering from this little ...

GEMMA Collins has today revealed the horrifyingly cruel nickname she was called before going on fat jabs. The TV favourite, ...

While research suggests having a higher weight may increase your risk for certain conditions, people can be healthy at every ...

GLP-1 receptor agonists, originally introduced in 2006, have undergone significant advancements over the years. David Ricks, ...

Key takeaways Projected return on investment in pharma research and development (R&D) in 2024 has risen to 5.9%, continuing the upward trajectory from 2023's 4.1%.GLP-1 therapies have played a ...